1. Advances on the in vivo and in vitro glycosylations of flavonoids
- Author
-
Meng Qiao, Xing Zhang, Li Jingmin, Lihui Zhang, Bingzhi Li, Han Xu, and Yuan Ji
- Subjects
Glycosylation ,Flavonoid ,Applied Microbiology and Biotechnology ,03 medical and health sciences ,chemistry.chemical_compound ,In vivo ,Glycosyltransferase ,heterocyclic compounds ,Glycosyl ,Glycosides ,Biotransformation ,030304 developmental biology ,Flavonoids ,chemistry.chemical_classification ,0303 health sciences ,biology ,030306 microbiology ,fungi ,Chemical glycosylation ,Glycosyltransferases ,food and beverages ,Glycosidic bond ,Biological activity ,General Medicine ,carbohydrates (lipids) ,chemistry ,Biochemistry ,Biocatalysis ,biology.protein ,Biotechnology - Abstract
Flavonoids possess diverse bioactivity and potential medicinal values. Glycosylation of flavonoids, coupling flavonoid aglycones and glycosyl groups in conjugated form, can change the biological activity of flavonoids, increase water solubility, reduce toxic and side effects, and improve specific targeting. Therefore, it is desirable to synthesize various flavonoid glycosides for further investigation on their medicinal values. Compared with chemical glycosylations, biotransformations catalyzed by uridine diphospho-glycosyltransferases provide an environmentally friendly way to construct glycosidic bonds without repetitive chemical synthetic steps of protection, activation, coupling, and deprotection. In this review, we will summarize the existing knowledge on the biotechnological glycosylation reactions either in vitro or in vivo for the synthesis of flavonoid O- and C-glycosides and other rare analogs.Key points• Flavonoid glycosides usually show improved properties compared with their flavonoid aglycones.• Chemical glycosylation requires repetitive synthetic steps and purifications.• Biotechnological glycosylation reactions either in vitro or in vivo were discussed.• Provides representative synthetic examples in detail.
- Published
- 2020